Latest filing published 01 Feb 2018 for Albireo Pharma, INC., €2.7M.
Filing timeline
BuySaleInsider track record
Phase4 Partners Ltd: trading record in brief
This profile gathers the share dealings of Phase4 Partners Ltd in Albireo Pharma, Inc. In total, 4 filings cover trades dated 30 January 2018.
Sales make up the whole of the open-market record (4 sales, €5.6M).
The latest filing, published on 7 February 2018, reports an open-market sale of €2.7M in Albireo Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Phase4 Partners Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 98,500 shares@ US$34.400698.4% of flowCommon StockSEC:0001140361-18-004481:0
- 1,500 shares@ US$37.05871.6% of flowCommon StockSEC:0001140361-18-004481:1
2 of 2 declarations
